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Abstract
DNA damage at the base-sequence, epigenome and chromosome level is a fundamental cause of developmental
and degenerative diseases. Multiple micronutrients and their interactions with the inherited and/or acquired gen-
ome determine DNA damage and genomic instability rates. The challenge is to identify for each individual the
combination of micronutrients and their doses (i.e. the nutriome) that optimises genome stability and DNA repair.
In this paper I describe and propose the use of high-throughput nutrient array systems with high content analysis
diagnostics of DNA damage, cell death and cell growth for defining, on an individual basis, the optimal nutriome
for DNA damage prevention and cancer growth control.
Background and Current Status
DNA damage at the base sequence, epigenome and
chromosome level is the most fundamental cause of
developmental and degenerative diseases (including
accelerated ageing) and is predictive prospectively of
these conditions [1-3]. Hundreds of genes are involved
in maintenance of genome integrity and there is great
variation amongst individuals with respect to common
polymorphisms that impact on the activity of these
enzymes [4-8]. The proteins encoded by those genes
required for DNA replication, DNA repair or detoxifica-
tion of potential genotoxins depend on essential cofac-
tors that are obtained from the diet for optimal function
[1,9] (Table 1; [9-24]). Dietary profile differs between
individuals to varying extents depending on their
acquired or inherited dietary preferences and food avail-
ability; furthermore uptake of micronutrients from the
digestive system and transport into cells of the body
also varies depending on genetics and altered expression
of transporters that occurs with age [25,26]. Nutritional
factors are not only required for genome maintenance
in vivo but also in vitro which varies greatly depending
on the culture medium used [27,28]. Maintenance of
genome integrity in vitro is critical particularly in long
term culture of cells (e.g. stem cells) which may be
taken out of the body for expansion and then returned
to the original donor or other recipients for medical
therapy reasons because DNA damage accumulated
in vitro may result in oncogenic events in stem cells
[29,30]. Currently dietary reference values (e.g. recom-
mended daily intakes, upper safety limits) and culture
medium recipes and conditions do not take into consid-
eration impact on genome integrity and yet harm to the
DNA sequence and/or the epigenome is the most fun-
damental and critical pathology underlying cellular and
organism health and disease.
Needs and Knowledge Gaps
A critical issue in tissue culture is the evident lack of phy-
siological conditions both in terms of composition of cul-
ture medium as well as oxygen tension both of which have
profound impacts on the rate of growth of cells and their
level of chromosomal instability. For example recipes of
culture media can vary enormously between each other
with respect to minerals and vitamins and often the con-
centration is supra-physiological relative to human serum
or deficient depending on the micronutrient. RPMI 1640
culture medium, one of the most commonly used for cul-
turing human cells, is supra-physiological for folate,
methionine and riboflavin and deficient for iron, copper,
zinc, calcium, magnesium and sulphur relative to human
serum (Table 2). While some of the deficiencies in culture
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serum this is only added at 5-10% which would still render
culture medium deficient if the micronutrient is absent or
deficient in the recipe. It is evident that current culture
media are not physiological relative to human plasma and
therefore data obtained from in vitro experiments need to
be treated with caution if attempts are made to extrapolate
to in vivo predictions. The latter can only become feasible
once physiological culture media are developed that are
equivalent in composition to human plasma and other
body fluids (e.g. cerebro-spinal fluid, interstitial fluid) and
if the oxygen tension used is similar to that experienced
by tissues in the body. Physiological oxygen tension is at
least 2-4 times lower than that of atmospheric oxygen
typically used in cell culture incubators; it was shown that
cells grown under physiological oxygen conditions experi-
ence less oxidative stress and paradoxically grow more
slowly compared to cells in atmospheric oxygen incuba-
tors [31,32]. Faster growth does not necessarily result in
better genome stability because the former could be due
to permissiveness of cell cycle checkpoints causing a
reduction in cell cycle time and/or reduced apoptosis of
cells with DNA damage.
We and others have shown that DNA damage, cell
death and cell growth in cultured cells are strongly
affected by concentration of essential micronutrients
such that both deficiency or excess within the physiolo-
gical range can profoundly harm the genome and alter
cell growth and survival kinetics [19,27,28,33,34]. The
use of excessively high concentrations of methyl donors
(e.g. folate, methionine, choline vitamin B12) in culture
medium theoretically may lead to an adverse DNA
methylation pattern that may inappropriately silence
important house-keeping genes although strong evi-
dence for this hypothesis is currently lacking [34]. It is
Table 1 Examples of the role and the effect of deficiency of specific micronutrients on genomic stability [9-24]
Micronutrient/s Role in genomic stability Consequence of deficiency
Vitamin C, Vitamin E,
antioxidant polyphenols
(e.g. caffeic acid)
Prevention of oxidation to DNA and lipid oxidation. Increased base-line level of DNA strand breaks,
chromosome breaks and oxidative DNA lesions and lipid
peroxide adducts on DNA.
Folate and Vitamins B2,
B6 and B12
Maintenance methylation of DNA; synthesis of dTMP from
dUMP and efficient recycling of folate.
Uracil misincorporation in DNA, increased chromosome
breaks and DNA hypomethylation.
Niacin Required as substrate for poly(ADP-ribose) polymerase (PARP)
which is involved in cleavage and rejoining of DNA and
telomere length maintenance.
Increased level of unrepaired nicks in DNA, increased
chromosome breaks and rearrangements, and sensitivity
to mutagens.
Zinc Required as a co-factor for Cu/Zn superoxide dismutase,
endonuclease IV, function of p53, Fapy glycosylase and in Zn
finger proteins such as PARP.
Increased DNA oxidation, DNA breaks and elevated
chromosome damage rate.
Iron Required as component of ribonucleotide reductase and
mitochondrial cytochromes.
Reduced DNA repair capacity and increased propensity
for oxidative damage to mitochondrial DNA.
Magnesium Required as co-factor for a variety of DNA polymerases, in
nucleotide excision repair, base excision repair and mismatch
repair. Essential for microtubule polymerization and
chromosome segregation.
Reduced fidelity of DNA replication. Reduced DNA repair
capacity. Chromosome segregation errors.
Manganese Required as a component of mitochondrial Mn superoxide
dismutase.
Increase susceptibility to superoxide damage to
mitochondrial DNA and reduced resistance to radiation-
induced damage to nuclear DNA.
Calcium Required as cofactor for regulation of the mitotic process and
chromosome segregation.
Mitotic dysfunction and chromosome segregation errors.
Selenium Selenoproteins involved in methionine metabolism and
antioxidant metabolism (e.g. selenomethionine, glutathione
peroxidase I).
Increase in DNA strand breaks, DNA oxidation and
telomere shortening.
Table 2 Comparison of concentration of some
micronutrients between a single sample of human serum








Folate μmol/L 0.028 2.3
Methionine μmol/L 30 100
Riboflavin μmol/L 0.05 0.53
Iron mg/L 0.84 0.19
Copper mg/L 1.4 <0.1
Zinc mg/L 0.94 0.17
Calcium mg/L 98 26
Magnesium mg/L 20 11
Sodium mg/L 3400 3200
Potassium mg/L 154 200
Phosphorous mg/L 121 174
Sulphur mg/L 1110 64
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required for genome maintenance and repair, the devel-
opment of physiological culture medium composition is
an important pre-requisite to enable the determination
of optimal culture conditions for growth of human cells
in a genomically stable state and to explore the impact
of various micronutrient combinations (i.e. nutriomes)
and dosages against different genetic backgrounds.
These developments are also critical if we are to use in
vitro data reliably to predict in vivo nutritional effects
on an individual basis. In this regard it is important to
note that concentrations of micronutrients achievable in
vitro might not be possible in vivo due to excretion and
re-distribution within tissues. Furthermore, with respect
to body fluids, we only have good knowledge on possi-
ble micronutrient concentrations in blood plasma and
our knowledge about interstitial fluids surrounding
organs (e.g. cerebrospinal fluid) or within tissues is at
this stage rudimentary. We need to consider optima
both within the physiological and supra-physiological
range but only use “physiological dose ranges” achiev-
able in vivo for in vivo predictions.
With respect to optimising in vitro and in vivo cellular
health it is becoming increasingly recognised that
parameters of genome and epigenome damage are
exquisitely sensitive to changes in micronutrient con-
centration even within the “normal” physiological range
[19,27,28,34-36]. It is therefore practical, feasible and
desirable to start re-examining dietary reference values
so that recommended intakes coincide with the
attainment of tissue concentrations that are consistent
with minimised DNA damage. For a detailed recent
review on the status of validation of DNA damage bio-
markers for measuring the genomic impact of malnutri-
tion and a proposed roadmap for determining nutrient
and nutriome requirements for optimal genome mainte-
nance refer to Fenech 2010 [1].
Testing Nutriomes in Nutrient Arrays
The biggest challenge in nutritional genomics is to make
the quantum leap from a reductionist single nutrient-
single gene interaction approach to studying the interac-
tion of the complete nutrient combination (i.e. the
nutriome) with the whole genome on an individual by
individual basis. The ultimate goal is effectively to find
for each individual the nutriome that best matches their
genome so that cellular function and genome and epi-
genome maintenance is optimised. The “Rosetta Stone”
(mechanism or code) to unravel this puzzle lies in devel-
oping nutrient arrays in microculture systems such that
multiple nutriomes can be simultaneously tested whilst
taking into consideration impact of dosage in the assess-
ment (figure 1). The microwell that produces cells than
can proliferate adequately and viably whilst maintaining
optimal genome and epigenome stability is likely to
represent the best nutriome match for that individual’s
cells. The development of high content automated ana-
lyses of DNA damage has already become feasible using
quantitative image cytometry [37-40] such that multiple
measures can be captured simultaneously in interphase
Figure 1 Nutrient arrays - The Rosetta Stone for unlocking personalised nutrition for genome maintenance. Theoretical example of a
simple Nutrient Array microculture system. NUT = single nutrient or multiple nutrient combination; A-E = different types of nutrients or nutrient
combinations; 1-3 = increasing dose levels. The different grey level colouring is simply an indication of the potential variability in cell growth,
viability and genome stability that may be observed depending on the combinations used. The challenge is to identify the best combination or
combinations for each individual.
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DNA content, multiple measures of genome stability
such as telomere length and aneuploidy by FISH,
oxidised guanine and DNA methylation by immunohis-
tochemistry, chromosome damage and telomere end
fusions by micronucleus cytome assays in cytokinesis-
blocked binuncleated cells and so on.
Such a system would also identify the deficiency and
safe upper limit range for that individual for multiple
micronutrients within a single scan and identify any
unexpected combinations that could prove counter-
intuitively cytotoxic or genotoxic. The plausibility of
such a possibility is supported by our observation that
genome instability increased under low folate conditions
(20 nM) if riboflavin concentration was increased to
replete status [28] (figures 2, 3, 4, 5) possibly because
the latter, which is the precursor of the FAD cofactor
for MTHFR, increases MTHFR activity which catalyses
the irreversible conversion of 5,10methylenetetrahydro-
folate to 5-methyltetrahydrofolate making the former
folate species less bioavailable for dTMP synthesis from
dUMP and thus increasing uracil in DNA. Excessive
uracil in DNA causes abasic sites and DNA strand
breaks when uracil glycosylases attempt to repair this
highly mutagenic lesion [35,41,42]. Therefore it is
important to develop a nutrient array system that can
efficiently interrogate multiple micronutrient combina-
tions at different dosages. This type of approach has the
added advantage that it becomes possible to identify an
individual’s nutriome for genome health maintenance
without needing to know the person’s genetic back-
ground. Furthermore, such systems could also be used
to compare the response of different genotypes under
the same nutriome conditions and estimate the percen-
tage of the variance of the biomarkers measured that
are explained by different genotype and different nutri-
ents in the nutriomes tested including their interactions
(see figures 2, 3, 4, 5 as an example for the effects of the
MTHFR C677T genotype relative to folic acid and ribo-
flavin on DNA damage, homocysteine and cell growth
biomarkers).
Prototypes of this approach have been designed by our
group and others to investigate the following interactive
effects on DNA damage, cell death and cell growth:
(i) different ratios of sulphur- and seleno-methionine
at constant physiological methionine concentration [33].
(ii) folate concentration with alcohol [43].
(iii) alcohol/acetaldehyde concentration and ADH1 or
ALDH2 genotype [44,45].
(iii) folate concentration with BRCA1 or BRCA2 geno-
type [46,47].
(iv) folate concentration with riboflavin concentration
with MTHFR C677T genotype [28].
In these studies the CBMNcyt assay was used to
obtain multiple measures of chromosomal instability,
cell death and cell division [48,49]. The results of this
approach are very promising because not only can they
readily define the % variation in genotoxicity,
Figure 2 Experimental Design. A schematic diagram of a simple nutrient array design that was used to study the interactive effects of folic
acid (F) and riboflavin (R) at low (L) and high (H) physiological concentration. In this study by Kimura et al 2004 [28] the folic acid-riboflavin
interactive effects in four different combinations (LFLR, LFHR, HFLR, HFHR) on DNA damage were measured using the CBMNcyt assay in
lymphocytes that were homozygous for the common or rarer allele of the C677T polymorphism in the methylenetetrahydrofolatereductase
(MTHFR) gene. Riboflavin is a precursor of the FAD cofactor for MTHFR and folic acid is a precursor for 5,10-methylenetetrahydrofolate the
substrate for MTHFR. Cell growth and homocysteine were also measured. N = 7 C677C, N = 7 T677T
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is attributable to a specific micronutrient, genotype and
interactions between these parameters but also define
the shape of the nutrient/DNA damage dose-response
curve for genetically defined cell types. The use of the
CBMNcyt assay is particularly relevant for this purpose
because the relative incidence of DNA damage, cell
death events and cytostasis varies as micronutrients and
their concentrations within a nutriome are increased or
decreased in multiple combinations. The relevant
nutriomes within a single metabolic pathway may
involve more than just two micronutrients; for example
the folate-methionine cycle requires folate in various
forms as a substrate and betaine, vitamin B12, vitamin
B6 and vitamin B2 as co-factors. Therefore, the nutrient
array should also be designed to interrogate combina-
tions of multiple micronutrients simultaneously in a
dose-related manner and at different or contrasting
dosage levels for each micronutrient relative to the
others.
The in vitro nutrient array system would also be an
ideal mechanism to test whether the predictions of
emerging nutrigenomic mathematical models in specific
key metabolic pathways [50,51] actually hold true
because this system is less likely than in vivo human
models to be affected by problems relating to compli-
ance to dietary intervention and unexpected life-style
and exposure variables such as stress and recreational
drug consumption as well as environmental genotoxi-
cants which can impact on the genome damage indices
measured. Furthermore it is financially prohibitive to
test multiple micronutrient combinations in vivo.
The Future
Realisation of the promise of nutrient array systems is
dependent on the following technological developments:
Figure 3 High riboflavin tends to increase genome instability when folate status is low. Folate-riboflavin interactive effects on CBMNcyt
assay DNA damage biomarkers. It is evident from these results that folate deficiency tends to increase micronuclei, nucleoplasmic bridges and
nuclear buds and these effects are further aggravated by high riboflavin in a low folic acid background. For more details refer to Kimura et al
2004 [28]. L, low; H, high; F, folic acid; R, riboflavin.
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composition of the culture medium to reflect exactly
the actual extracellular fluid composition in diverse
tissue environments (e.g. plasma, cerebrospinal fluid)
as well as the correct oxygen tension which can
modify susceptibility and rate of nuclear and cell
division.
2. The issue of nutrient requirements based on cell
division kinetics could be significant but remains
unexplored. Nutrient array systems will need to be
developed for both dividing and non-dividing (con-
fluent) cell cultures including 3 D cultures with
mixed populations of dividing and non-dividing cells
to test whether nutritional requirements for genome
maintenance might vary depending on cell division
status.
3. Because of the very large number of possible combi-
nations of micronutrients (vitamins, minerals, phyto-
nutrients, antioxidants and amino acids) a high
throughput system is required that will be able to mea-
sure cell growth, cell death and DNA damage
biomarkers in micro-cultures of cells using high con-
tent analyses with live cell-imaging systems that ideally
will perform such measurements simultaneously in a
manner that is not destructive of cells so that continu-
ous measurements can be performed over several days
with minimal cell number requirements (figure 6). The
ability to perform continuous measurements over sev-
eral days or weeks is particularly relevant to nutrition
because the effects of micronutrients are chronic
rather than acute and their impact could drift as cells
adapt to the different nutriome environments that they
are exposed to in the nutrient array system.
4. Ideally such systems will be able to interrogate not
only the optimal nutritional requirements for growth
and genome maintenance of normal cells from an
individual but also to verify that such a nutriome
does not stimulate growth of cancer cells that the
individual might have. Cancer cells are likely to have
a markedly different genotype to that of the host’s
normal cells and could respond differently to the
same nutriome environment. For example some
Figure 4 Effect of MTHFR C677C and T677T genotype on DNA damage, homocysteine and cell growth. The differential effects of the
MTHFR C677T genotype on micronuclei, nuclear buds, homocysteine and cell growth. It is evident from the results of this study that
homozygous carriers of the T allele tended to have higher levels of micronuclei, homocysteine and cell growth and lower frequencies of nuclear
buds relative to homozygous carriers of the common C allele. For more details refer to Kimura et al 2004 [28]. * P < 0.05 relative to
corresponding CC
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tor [52] giving them a distinct advantage over nor-
mal cells, when folate is limiting, in accessing folate
from the surrounding fluid. The ideal nutriome for
an ageing or cancer-prone individual would be the
combination that not only sustains the replenish-
ment of normal cells in a genetically integral manner
but also inhibits the growth of cancer cells. It is con-
ceivable that both normal cells and cancer cells from
an individual could be simultaneously tested within
a single nutrient array system.
5. Ultimately, although such systems can be readily
implemented for optimising in vitro culture condi-
tions of cells, their practical use will be greatly
enhanced once they have been validated for predict-
ing the in vivo nutritional requirements of an indivi-
dual. The data from the optimal in vitro nutriome,
after comparison to plasma concentration, can then
be used to estimate deficiencies or excesses of
micronutrients in body fluids and appropriate dietary
intervention can then be designed to make the
necessary adjustments to optimise genome stability.
This approach could be used in the emerging
Figure 5 Percentage of variation of DNA damage biomarkers,
homocysteine and cell growth explained by genotype, folic
acid or riboflavin. Percentage variation of micronucleus,
nucleoplasmic bridge, nuclear bud frequency, homocysteine
concentration and cell growth explained by folic acid or riboflavin
concentration or MTHFR C677T genotype. It is evident that folic acid
is the dominant variable with respect to DNA damage biomarkers,
whilst MTHFR C677T genotype was almost as important as folic acid
in explaining the degree of variation for homocysteine and cell
growth. Riboflavin only appeared to have some substantial but
small effect on the variation of nucleoplasmic bridges and
homocysteine. For more details refer to Kimura et al 2004 [28].
Figure 6 Minimally invasive high-throughput nutrient array screening for genome-protective agents. A schematic diagram of the
essential components of a high throughput high-content-analysis automated nutrient array system using human peripheral blood lymphocytes.
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on Genome Health Clinics in which developmental
and degenerative diseases are prevented via diagnosis
and nutritional prevention of DNA damage [11,53].
Whether such attempts to optimise micronutrient
status should be limited to those with above average
DNA damage levels will remain an open question
until we can find out what is the lowest DNA
damage level achievable in vitro or in vivo.
6. Whether the nutrient array system can be adapted
for use directly with an individual’s sample of their
own body fluids is an important question as this may
be a better basis for in vitro testing of the efficacy of
multiple nutritional adjustments under conditions
that reflect exactly the individual’s current physiologi-
cal status. Although this approach seems attractive its
feasibility has yet to be explored and could be limited
by the difficulty of culturing cells in human serum.
7. There will always be a need to review and revise
the DNA damage biomarkers that are most suitable
for use in the nutrient array system based on their
status of validation. At this point in time the cyto-
kinesis-block micronucleus assay is the best validated
with respect to its sensitivity to nutritional status
and prospective association with cancer and cardio-
vascular disease mortality [1,54-57]. Ultimately an
automated high content analysis approach that inte-
grates multiple complementary biomarkers of gen-
ome damage and instability (e.g. mitochondrial DNA
mutations, telomere length, DNA methylation,
micronuclei, nucleoplasmic bridges) would be
required to achieve a deeper understanding of opti-
mal nutritional requirements for genome mainte-
nance on an individual basis.
8. Peripheral blood lymphocytes are ideal for use in
the nutrient array system because they are easy to
o b t a i na n dc u l t u r ea n dh a v eb e e nu s e de x t e n s i v e l y
to measure DNA damage in vitro and in vivo.
Furthermore, because they travel throughout the
body they experience fluctuations in micronutrient
concentrations and nutriome profiles that may occur
in different tissues and therefore can integrate the
genomic impacts of sub-optimal nutrition through-
out the body. Whether, the effects in lymphocytes
might reflect what would happen in other tissues,
such as epithelial tissues, is an important question
because it is difficult to culture easily accessible
epithelial tissues such as buccal mucosa. Two recent
studies suggest that the level of micronuclei in lym-
phocytes correlates well with micronuclei in buccal
cells and with DNA damage in sperm [58,59]. How-
ever, despite these promising results more evidence
is needed to justify the sole use of lymphocytes in
the nutrient array system and ideally a practical
epithelial cell culture alternative is also developed in
the future.
In conclusion the use of nutrient array systems to
interrogate genomic responses to multiple nutrient
doses and combinations is in principle feasible and
holds great promise to define the nutriome require-
ments of any cell type to either sustain its growth and
reproduction in a genetically stable manner in the case
of normal cells and stem cells or to suppress its growth
and cause its death in the case of cancer cells.
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